Functional Selectivity and Antidepressant Activity of Serotonin 1A Receptor Ligands
- PMID: 26262615
- PMCID: PMC4581256
- DOI: 10.3390/ijms160818474
Functional Selectivity and Antidepressant Activity of Serotonin 1A Receptor Ligands
Abstract
Serotonin (5-HT) is a monoamine neurotransmitter that plays an important role in physiological functions. 5-HT has been implicated in sleep, feeding, sexual behavior, temperature regulation, pain, and cognition as well as in pathological states including disorders connected to mood, anxiety, psychosis and pain. 5-HT1A receptors have for a long time been considered as an interesting target for the action of antidepressant drugs. It was postulated that postsynaptic 5-HT1A agonists could form a new class of antidepressant drugs, and mixed 5-HT1A receptor ligands/serotonin transporter (SERT) inhibitors seem to possess an interesting pharmacological profile. It should, however, be noted that 5-HT1A receptors can activate several different biochemical pathways and signal through both G protein-dependent and G protein-independent pathways. The variables that affect the multiplicity of 5-HT1A receptor signaling pathways would thus result from the summation of effects specific to the host cell milieu. Moreover, receptor trafficking appears different at pre- and postsynaptic sites. It should also be noted that the 5-HT1A receptor cooperates with other signal transduction systems (like the 5-HT1B or 5-HT2A/2B/2C receptors, the GABAergic and the glutaminergic systems), which also contribute to its antidepressant and/or anxiolytic activity. Thus identifying brain specific molecular targets for 5-HT1A receptor ligands may result in a better targeting, raising a hope for more effective medicines for various pathologies.
Keywords: antidepressant activity; receptor trafficking; serotonin 1A receptors.
Figures
![Figure 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4581256/bin/ijms-16-18474-g001.gif)
![Figure 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4581256/bin/ijms-16-18474-g002.gif)
![Figure 3](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4581256/bin/ijms-16-18474-g003.gif)
![Figure 4](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4581256/bin/ijms-16-18474-g004.gif)
![Figure 5](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4581256/bin/ijms-16-18474-g005.gif)
![Figure 6](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4581256/bin/ijms-16-18474-g006.gif)
Similar articles
-
Serotonin 5-HT1A receptors as targets for agents to treat psychiatric disorders: rationale and current status of research.CNS Drugs. 2013 Sep;27(9):703-16. doi: 10.1007/s40263-013-0071-0. CNS Drugs. 2013. PMID: 23757185 Review.
-
N-desalkylquetiapine, a potent norepinephrine reuptake inhibitor and partial 5-HT1A agonist, as a putative mediator of quetiapine's antidepressant activity.Neuropsychopharmacology. 2008 Sep;33(10):2303-12. doi: 10.1038/sj.npp.1301646. Epub 2007 Dec 5. Neuropsychopharmacology. 2008. PMID: 18059438
-
Review of antidepressants in clinic and active ingredients of traditional Chinese medicine targeting 5-HT1A receptors.Biomed Pharmacother. 2019 Dec;120:109408. doi: 10.1016/j.biopha.2019.109408. Epub 2019 Sep 18. Biomed Pharmacother. 2019. PMID: 31541883 Review.
-
5-HT1A receptor stimulation in the medial prefrontal cortex mediates the antidepressant effects of mGlu2/3 receptor antagonist in mice.Neuropharmacology. 2018 Jul 15;137:96-103. doi: 10.1016/j.neuropharm.2018.05.001. Epub 2018 May 5. Neuropharmacology. 2018. PMID: 29738849
-
Antidepressant-like activity and safety profile evaluation of 1H-imidazo[2,1-f]purine-2,4(3H,8H)-dione derivatives as 5-HT1A receptor partial agonists.PLoS One. 2020 Aug 7;15(8):e0237196. doi: 10.1371/journal.pone.0237196. eCollection 2020. PLoS One. 2020. PMID: 32764777 Free PMC article.
Cited by
-
N-(3-((3-(trifluoromethyl)phenyl)selanyl)prop-2-yn-1-yl) benzamide induces antidepressant-like effect in mice: involvement of the serotonergic system.Psychopharmacology (Berl). 2024 Apr 18. doi: 10.1007/s00213-024-06588-8. Online ahead of print. Psychopharmacology (Berl). 2024. PMID: 38635075
-
Association of HTR1A Gene Polymorphisms with Efficacy and Plasma Concentrations of Atypical Antipsychotics in the Treatment of Male Patients with Schizophrenia.Neuropsychiatr Dis Treat. 2024 Jan 30;20:185-193. doi: 10.2147/NDT.S449096. eCollection 2024. Neuropsychiatr Dis Treat. 2024. PMID: 38312123 Free PMC article.
-
A Cross-Sectional Study on the Relationship Among Cytokines, 5-HT2A Receptor Polymorphisms, and Sleep Quality of Non-manual Workers in Xinjiang, China.Front Psychiatry. 2022 Apr 6;13:777566. doi: 10.3389/fpsyt.2022.777566. eCollection 2022. Front Psychiatry. 2022. PMID: 35463508 Free PMC article.
-
The G Protein-Coupled Serotonin 1A Receptor Augments Protein Kinase Cε-Mediated Neurogenesis in Neonatal Mouse Hippocampus-PKCε-Mediated Signaling in the Early Hippocampus.Int J Mol Sci. 2022 Feb 10;23(4):1962. doi: 10.3390/ijms23041962. Int J Mol Sci. 2022. PMID: 35216076 Free PMC article.
-
In Vitro and In Silico Characterization of G-Protein Coupled Receptor (GPCR) Targets of Phlorofucofuroeckol-A and Dieckol.Mar Drugs. 2021 Jun 4;19(6):326. doi: 10.3390/md19060326. Mar Drugs. 2021. PMID: 34199834 Free PMC article.
References
-
- Raymond J.R., Mukhin Y.V., Gelasco A., Turner J., Collinsworth G., Gettys T.W., Grewal J.S., Garnovskaya M.N. Multiplicity of mechanisms of serotonin receptor signal transduction. Pharmacol. Ther. 2001;92:179–212. - PubMed
-
- Artigas F. Developments in the field of antidepressants, where do we go now? Eur. Neuropsychopharmacol. 2015;25:657–670. - PubMed
-
- Jacobs B.L., Azmitia E.C. Structure and function of the brain serotonin system. Physiol. Rev. 1992;72:165–229. - PubMed
-
- Artigas F. Serotonin receptors involved in antidepressant effects. Pharmacol. Ther. 2013;137:119–131. - PubMed
-
- Adell A., Celada P., Abellan M.T., Artigas F. Origin and functional role of the extracellular serotonin in the midbrain raphe nuclei. Brain Res. Brain Res. Rev. 2002;39:154–180. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical